AFMoC Enhances Predictivity of 3D QSAR: A Case Study with DOXPreductoisomerase - PowerPoint PPT Presentation

1 / 26
About This Presentation
Title:

AFMoC Enhances Predictivity of 3D QSAR: A Case Study with DOXPreductoisomerase

Description:

Adaptation of fields for Molecular Comparison (AFMoC) ... Active conformations and molecular alignments are determined with protein-ligand ... – PowerPoint PPT presentation

Number of Views:160
Avg rating:3.0/5.0
Slides: 27
Provided by: ntsup
Category:

less

Transcript and Presenter's Notes

Title: AFMoC Enhances Predictivity of 3D QSAR: A Case Study with DOXPreductoisomerase


1
AFMoC Enhances Predictivity of 3D QSAR A Case
Study with DOXP-reductoisomerase
  • K. Silber, P. Heidler, T. Kurz, G. Klebe
  • J. Med. Chem. 48(2005) 3547-3563

Journal Club, Presented by Lei Xie
2
Motivations
  • No other papers read
  • Interested in interface of biology and chemistry
  • Inspired by a talk on nuclear receptors in the
    group meeting

3
Motivations
  • No other papers read
  • Interested in interface of biology and chemistry
  • Inspired by a talk in the group meeting

4
Outlines
  • Basic of 3D-QSAR
  • Discussion of the paper
  • Ideas derived from the paper

5
Concept of 3D QSAR
  • Correlates spatially located features across a
    chemical series with biological activity
  • Procedures
  • 1. Selection of active conformation
  • 2. Alignment of conformers
  • 3. 3D field calculation in a box and grids
  • 4. Derivation and validation of models

6
Step 1 Selection of Active Conformation
O
  • Global minimum-enery conformation
  • Active analogs and pharmacophores
  • Protein-ligand complex
  • Intuitions

N
7
Step2 Alignment of conformers
  • Manuel pharmacophore or moments of inertia
  • Semi-automatic overlap of steric and
    electrostatic
  • Fully-automatic fragment re-construction
  • No alignment

O
N
8
Step 3 3D field calculation in grids
  • CoMFA
  • Lennard-Jones and
  • Coulomb interactions
  • CoMSIA
  • molecular similarity

O
N
9
Step 4 Derivation and validation of models
M1 M2 M3 . Mn
  • Regression, classification or clustering
  • in a mxn matrix
  • Challenges in
  • experimental design,
  • feature selections and model validations

W1 E1 W2 E2 . . . Wm Em
Y
10
Adaptation of fields for Molecular Comparison
(AFMoC)A technique to combine protein-ligand
interaction and 3D-QSAR to improve selection of
active conformation, alignment quality, affinity
prediction
11
Concept of AFMoC Step 1
  • Active conformations and molecular alignments are
    determined with protein-ligand docking

O
N
12
Concept of AFMoC Step 2
  • Decompose the general scoring function at each of
    grids in the binding pocket
  • Interaction fields are yielded by considering the
    contribution of the binding ligand to each of the
    grids

O
N
13
Concept of AFMoC Step 3
M1 M2 M3 . Mn
  • Regression with experimental affinity data to
    obtain binding models for specified protein
    family
  • Balance between the general and specific scoring
    function depending on the training data

W1 E1 W2 E2 . . . Wm Em
Y
14
DOXP-reductoisomerase(DXR)A new drug target for
multidrug-resistance malaria
15
DXR structures
  • Challenges in structure-based drug design
  • Contains metal-ligand coordination
  • Requires cofactor binding
  • - Possesses a large flexible loop

16
Training and Testing Data
  • 27 for model building
  • 14 for testing
  • Testing data set includes functional groups that
    are not included in the training data

17
Results Regression Models
  • CoMFA, CoMSIA, and AFMoC all derived
    statistically-significant models

Figure 5 (a) Experimentally determined binding
affinities versus fitted predictions using the
derived 3D QSAR models for the training set.
Results are shown applying the optimal number of
components, which is 5 for CoMFA ( ) and 4 for
CoMSIA ( ), respectively. (b) Experimentally
determined binding affinities versus fitted AFMoC
predictions for the 27 training set
DOXP-reductoisomerase inhibitors. Both
experimental and calculated values are shown
considering only the part of binding affinity
(pIC50PLS) used in PLS analysis ( ) or
considering the total binding affinity ( ). In
addition to the line of ideal correlation, dashed
lines are depicted to indicate deviations of one
logarithmic unit from ideal prediction.
18
Results Prediction Power
  • CoMFA and CoMSIA fail for ligands comprising
    functional groups not present in or exhibiting
    minor structural differences from the training
  • AFMoC is capable to correlate structural changes
    with affinity
  • General docking methods do not perform as well as
    AFMoC

a Values are given considering only the pair
potentials for the prediction or considering also
the solvent-accessible surface term (values in
parentheses).b Squared correlation coefficient.c
In logarithmic units.d Values are given for the
optimal number of components, which are 4 for
AFMoC, 5 for CoMFA, and 4 for CoMSIA.e Values in
italics denote lacking correlation.
19
Results General vs. Adapted
  • Best mixture of general and adapted model depends
    on the available training data.

Figure 8 Dependence of squared correlation
coefficient (r2) for AFMoC models on the mixing
coefficient between original DrugScore
potentials ( 0) and specifically adapted AFMoC
fields (PLS-model, 1).
20
Summary on the Paper
  • Protein structure information, even not perfect,
    is valuable for 3D-QSAR studies
  • Protein family adapted scoring functions is
    superior to general one
  • A general framework can be extend to other studies

21
Genome-wide Prediction of Protein-Ligand
Interactions
22
Scopes
  • Prediction of protein-ligand binding specificity
    given a protein sequence and a ligand

23
Procedures
  • Decomposition of scoring functions with amino
    acid residues and identification of hot spot
    with known protein structures for a protein
    family
  • Derivation of regression or classification models
    that correlate binding ligands and evolutionary
    profiles at the hot spot
  • Exploration of genome sequences based on
    sequence/structure alignments and phylogenetic
    analysis
  • Extension with functional site characterization
    and analysis

24
Applications
  • Drug Discovery
  • Target verifications, Lead discovery, Drug
    resistance (HIV, Gleevac), Off-target
    identifications
  • Protein design
  • Nature product identification

25
Data
  • Protein structure (not necessary complex)
  • Binding affinity
  • Availability
  • PDBBind - Structure abundant families (protein
    kinase, matrix metalloproteases etc.)
  • Structural genomics structure
  • NIH chemical genomics initiative binding
    affinity
  • High throughput screening and combinatorial
    library
  • Protein chips and other techonologies

26
THANKS
Write a Comment
User Comments (0)
About PowerShow.com